Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents
Bioorganic Chemistry · 2024-10 · 151 · 107682
DOI: 10.1016/j.bioorg.2024.107682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024-10. Verfasst von Bassem H Naguib und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt; Department of Pharmaceutical Chemistry, Faculty of …. Hauptthemen laut MEDLINE: Coumarins, Proto-Oncogene Proteins c-met, STAT3 Transcription Factor, Antineoplastic Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 99 Literaturangaben.
Abstract (Originalsprache)
c-MET and STAT-3 are significant targets for cancer treatments. Here, we describe a class of very effective dual STAT-3 and c-MET inhibitors with coumarin-based thiazoles (3a-o) as its scaffold. Spectroscopic evidence (NMR, HRMS, and HPLC) validated the structural discoveries of the new compounds. The cytotoxic activity of these compounds was also tested against a panel of cancer cells in accordance with US-NCI guidelines. Compound 3g proved to be active at 10 µM, thus it was automatically scheduled to be tested at five doses. Towards SNB-75 (CNS cancer cell line), compound 3g showed notable in vitro anti-cancer activity with GI50 = 1.43 μM. For the molecular targets, compound 3g displayed potent activity towards STAT-3 and c-MET having IC50 of 4.7 µM and 12.67, respectively, compared to Cabozantinib (IC50 = 15 nM of c-MET) and STAT-3-IN-3 (IC50 = 2.1 µM of STAT-3). Moreover, compound 3g significantly induced apoptosis in SNB-75 cells, causing a 3.04-fold increase in apoptotic cell death (treated cells exhibited 11.53 % overall apoptosis, against 3.04 % in reference cells) and a 3.58-fold increase in necrosis. Moreover, it arrests cells at the G2 phase. Dual inhibition of c-MET and STAT-3 protein kinase was further validated using RT-PCR. The target compound's binding mechanism was determined by the application of molecular docking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Cairo 1183…
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
- Department of Chemistry, College of Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates; Chemistry Department, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Cairo 11837, Egypt; The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British Un…
- Department of Chemistry, School of Science, The University of Jordan, Amman 11942, Jordan.
- Zoology Department, Faculty of Science, Suez Canal University, P.O. 41522, Ismailia, Egypt.
Zitieren
APA
Naguib, B. H., Elsebaie, H. A., Nafie, M. S., Mohamady, S., Albujuq, N. R., Samir Ayed, A., Nada, D., Khalil, A. F., Hefny, S. M., Tawfik, H. O., & Shaldam, M. A. (2024). Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents. Bioorganic Chemistry, 151, 107682. https://doi.org/10.1016/j.bioorg.2024.107682
Vancouver
Naguib BH, Elsebaie HA, Nafie MS, Mohamady S, Albujuq NR, Samir Ayed A, et al. Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents. Bioorganic Chemistry. 2024;151:107682. doi:10.1016/j.bioorg.2024.107682
BibTeX
@article{Naguib2024,
author = {Naguib, Bassem H and Elsebaie, Heba A and Nafie, Mohamed S and Mohamady, Samy and Albujuq, Nader R and Samir Ayed, Aya and Nada, Dina and Khalil, Ahmed F and Hefny, Salma M and Tawfik, Haytham O and Shaldam, Moataz A},
title = {Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents},
journal = {Bioorganic Chemistry},
year = {2024},
volume = {151},
pages = {107682},
doi = {10.1016/j.bioorg.2024.107682}
}
EUVIMED